The clinical use of blood-test factors for Alzheimer’s disease: improving the prediction of cerebral amyloid deposition by the QPLEX(TM)Alz plus assay kit

Alzheimer’s disease (AD) is the leading cause of dementia, and many studies have focused on finding effective blood biomarkers for the accurate diagnosis of this disease. Predicting cerebral amyloid deposition is considered the key for AD diagnosis because a cerebral amyloid deposition is the hallma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Haeng Jun, Park, Jong-Chan, Jung, Keum Sim, Kim, Jiyeong, Jang, Ji Sung, Kwon, Sunghoon, Byun, Min Soo, Yi, Dahyun, Byeon, Gihwan, Jung, Gijung, Kim, Yu Kyeong, Lee, Dong Young, Han, Sun-Ho, Mook-Jung, Inhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257730/
https://www.ncbi.nlm.nih.gov/pubmed/34108650
http://dx.doi.org/10.1038/s12276-021-00638-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257730/
https://www.ncbi.nlm.nih.gov/pubmed/34108650
http://dx.doi.org/10.1038/s12276-021-00638-3

Ejemplares similares